Soundwaves vs. Cancer: Michigan's $10M Breakthrough

ANN ARBOR, MI — Imagine beating cancer without radiation, without chemo, and without a single scalpel. That's not science fiction anymore. That's American ingenuity at work.

Michigan Medicine just dropped $10 million to launch a new center dedicated to histotripsy, a non-invasive treatment that uses soundwaves to literally tear tumors apart. No cutting. No poisoning. No burning. Just sound.

What is histotripsy and how does it work?

Invented in 2002 by University of Michigan professor Zhen Xu and her colleagues, histotripsy targets cancerous tissue with precise soundwave patterns. Those waves create gas clouds inside the tumor, and when they expand and collapse, they shred the cancer cells. What's left is a liquid the body flushes out naturally.

It's already FDA-approved for liver tumors, and 5,000 patients have been treated. But Xu says this is just the beginning.

“In the next half decade, I envision the Histotripsy Center expanding from our lab to support thousands of researchers around the country,” Xu said.

Why does this matter for patients?

Forget the brutal side effects of traditional treatments. Histotripsy means no recovery time, no radiation burns, no chemo fog. It also opens the door to treating cancers that were previously untouchable.

Xu notes the only exceptions are certain stomach cancers and lung cancer, since lungs are full of air pockets that would interfere with the technique. But for everything else, this is a game-changer.

What will the $10 million fund?

The money comes from HistoSonics, Michigan Engineering, and private donors. It will fuel research, clinical trials, and training for up to 12 doctoral students a year. The goal is ambitious: 3 to 5 new FDA approvals and treatment for hundreds of thousands of patients within five years.

U-M President Domenico Grasso compared histotripsy to the university's historic work on polio and influenza vaccines. That's a bold claim, but the results so far back it up.

Is histotripsy a replacement for traditional cancer treatments?

No. Xu is clear that this is “one more option” in the fight against cancer, not a silver bullet. But it's a powerful one, and it's being developed right here in America, by American researchers, for American patients.

While the federal government bickers and bureaucrats stall, Michigan's brightest minds are doing what Americans do best: solving problems, saving lives, and proving that free enterprise and innovation beat government mandates every time.

This is the American Dream in action. Soundwaves, science, and the relentless pursuit of a cure.